Flanigan's Enterprises (BDL)
(Delayed Data from AMEX)
$26.18 USD
-0.25 (-0.95%)
Updated Aug 23, 2024 02:07 PM ET
After-Market: $25.76 -0.42 (-1.60%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$26.18 USD
-0.25 (-0.95%)
Updated Aug 23, 2024 02:07 PM ET
After-Market: $25.76 -0.42 (-1.60%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Flanigan's (BDL) Q3 Earnings Decline Y/Y, Revenues Improve
by Zacks Equity Research
Strength in the majority of Flanigan's (BDL) sales drives its fiscal third-quarter revenues.
The Zacks Analyst Blog Highlights Alphabet, AbbVie, Qualcomm and Flanigan's
by Zacks Equity Research
Alphabet, AbbVie, Qualcomm and Flanigan's are part of the Zacks top Analyst Blog.
Top Research Reports for Alphabet, AbbVie & QUALCOMM
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Alphabet Inc. (GOOGL), AbbVie Inc. (ABBV) and QUALCOMM Incorporated (QCOM), as well as a micro-cap stock Flanigan's Enterprises, Inc. (BDL).
Zacks Initiates Coverage of Flanigan's With Neutral Recommendation
by Debanjana Dey
Find out why Zacks rates Flanigan's as "Neutral", being the first on Wall Street to initiate coverage on the stock. Explore BDL's market positioning and financial health amid operational challenges.
The Zacks Analyst Blog Highlights Stocks recently featured in the blog include: Novo Nordisk, TotalEnergies, U.S. Bancorp and Flanigan's
by Zacks Equity Research
Novo Nordisk, TotalEnergies, U.S. Bancorp and Flanigan's are included in this Analyst Blog.
Top Analyst Reports for Novo Nordisk, TotalEnergies & U.S. Bancorp
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Novo Nordisk A/S (NVO), TotalEnergies SE (TTE) and U.S. Bancorp (USB), as well as a micro-cap stock Flanigan's Enterprises, Inc. (BDL).